T1	SNP 0 9	Variation
T5	Association 69 73	risk
E1	Association:T5 bc:T6 snp_int:T1
T6	Cancer 77 104	contralateral breast cancer
A1	Cancer_Type T6 Other
T8	Spec 566 574	examined
T9	SNP 583 591	variants
T10	Entity 595 646	genes related to obesity, weight, and weight change
R5	SNP_coupled_gene Arg1:T9 Arg2:T10	
T11	Association 651 661	associated
E2	Association:T11 bc:T12 snp_int:T9
R6	Speculation_marker Arg1:E2 Arg2:T8	
T12	Cancer 667 670	CBC
R7	Equiv Arg1:T12 Arg2:T6	
T7	Entity 689 697	20 genes
T13	SNP 677 685;699 702	Variants 182
R4	SNP_coupled_gene Arg1:T13 Arg2:T7	
T14	SNP 703 734	single-nucleotide polymorphisms
T15	SNP 736 739	SNP
R8	Equiv Arg1:T15 Arg2:T14	
T16	Entity 754 779	adipose tissue metabolism
T17	Entity 781 795	energy balance
T18	Entity 797 814	insulin resistanc
T19	Entity 821 833	inflammation
R9	Member Arg1:T7 Arg2:T16	
R10	Member Arg1:T7 Arg2:T17	
R11	Member Arg1:T7 Arg2:T18	
R12	Member Arg1:T7 Arg2:T19	
T20	Entity 913 916	BMI
T21	Entity 921 937	type II-diabetes
R13	Member Arg1:T7 Arg2:T20	
R14	Member Arg1:T7 Arg2:T21	
R15	Equiv Arg1:T10 Arg2:T7	
R16	Equiv Arg1:T9 Arg2:T13	
T2	Entity 13 64	genes related to obesity, weight, and weight change
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
R2	Equiv Arg1:T2 Arg2:T10	
T3	Spec 957 965	examined
T4	SNP 990 998	variants
T22	Entity 1002 1013	these genes
R3	SNP_coupled_gene Arg1:T4 Arg2:T22	
R17	Equiv Arg1:T4 Arg2:T13	
R18	Equiv Arg1:T22 Arg2:T7	
T23	Association 1022 1026	risk
E3	Association:T23 bc:T24 snp_int:T4
T24	Cancer 1030 1033	CBC
R19	Speculation_marker Arg1:E3 Arg2:T3	
T25	Entity 1040 1049	Caucasian
R20	Population_assignment Arg1:T4 Arg2:T25	
T26	Entity 1163 1168	Women
R21	Population_assignment Arg1:T4 Arg2:T26	
T27	Level 1316 1344	no statistically significant
T28	Association 1345 1357	associations
E4	Association:T28 snp_int:T29 snp_int2:T33 bc:T30
A2	Level E4 Low
R22	Level_marker Arg1:E4 Arg2:T27	
T29	SNP 1366 1377	any variant
T30	Cancer 1382 1385	CBC
R24	Equiv Arg1:T13 Arg2:T29	
T31	Entity 1420 1430	menopausal
T32	Entity 1434 1451;1457 1463	estrogen receptor status
T33	SNP 1366 1377	any variant
R25	Risk_Factor Arg1:T33 Arg2:T31	
R26	Risk_Factor Arg1:T33 Arg2:T32	
R23	SNP_coupled_gene Arg1:T33 Arg2:T7	
R27	Population_assignment Arg1:T33 Arg2:T25	
R28	Population_assignment Arg1:T33 Arg2:T26	
T34	Neg 1586 1588	no
T35	Association 1589 1600	association
E5	Association:T35 snp_int:T36 bc:T38
R29	Negation_marker Arg1:E5 Arg2:T34	
T36	SNP 1609 1618	variation
T37	Entity 1622 1643	obesity-related genes
R30	SNP_coupled_gene Arg1:T36 Arg2:T37	
T38	Cancer 1656 1659	CBC
R31	Population_assignment Arg1:T36 Arg2:T25	
T39	Entity 1500 1505	women
R32	Population_assignment Arg1:T36 Arg2:T39	
T40	Entity 1511 1530	early-onset disease
R33	Risk_Factor Arg1:T36 Arg2:T40	
T41	Entity 1535 1574	survive a first breast cancer diagnosis
R34	Risk_Factor Arg1:T36 Arg2:T41	
T42	SNP 1661 1677	Genetic variants
T43	Entity 1681 1705	genes related to obesity
R35	SNP_coupled_gene Arg1:T42 Arg2:T43	
T44	Spec 1714 1720	likely
T45	Neg 1710 1713	not
T46	Level 1724 1732	strongly
T47	Association 1733 1742	influence
E6	Association:T47 bc:T48 snp_int:T42
A3	Level E6 High
R37	Level_marker Arg1:E6 Arg2:T46	
R38	Speculation_marker Arg1:E6 Arg2:T44	
R36	Negation_marker Arg1:E6 Arg2:T45	
T48	Cancer 1775 1803	second primary breast cancer
A4	Cancer_Type T48 Recurrent
